https://www.selleckchem.com/pr....oducts/DAPT-GSI-IX.h
40 (22.1%) patients had score ? 2 both Achilles and plantar spur. In this group, the mean age was older and the proportion of metabolic comorbidities was higher than the groups of Achilles and plantar spur with score 0 or 1. Predictor of the development of large or moderate-severe calcaneal spur was the existence of metabolic comorbidity [OR (95%CI) 3.49 (1.11-11. and p=0.033]. The presence of metabolic comorbidities increases the frequency of calcaneal spurs in gout patients. This condition can be explained by the impaired microv
Like
Comment
Share
